EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers

Luke J Kubiatowicz, Nima Pourafzal, Audrey T Zhu, Zhongyuan Guo, Ronnie H Fang, Liangfang Zhang iD

Small Methods · 2026-01 · 10 (2)

DOI: 10.1002/smtd.202500624 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 16.06.2025. Verfasst von Luke J Kubiatowicz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San …. Hauptthemen laut MEDLINE: Nanomedicine, Drug Delivery Systems. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Defense Threat Reduction Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral drug delivery is highly desirable for medical intervention due to its convenience, patient adherence, and non‐invasiveness. Despite significant efforts, the successful oral delivery of therapeutics and prophylactics has been largely hindered by biological barriers that limit bioavailability. Researchers have since turned to nanoparticles as promising delivery vehicles that offer tunable properties to protect therapeutic payloads and enhance transport across these barriers. In addition to material optimization and delivery strategies, biomimetic designs—particularly those inspired by viruses—have significantly advanced the field, leveraging natural mechanisms to penetrate mucosal layers through size, charge, and enzymatic functions. This review examines the key physiological challenges limiting oral drug absorption, including the harsh gastric environment, the mucosal layer, and the polarized epithelial barrier. Recent preclinical advancements are then highlighted in nanoparticle engineering aimed at overcoming these barriers and improving bioavailability. Continued innovation in oral nanomedicine holds immense potential to revolutionize treatment paradigms, enhancing both therapeutic efficacy and patient outcomes worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineDrug Delivery SystemsHumansAdministration, OralAnimalsNanoparticlesBiological Availability

Stichwörter der Autor:innen

gastrointestinal tractmucus penetrationnanomedicinenanoparticleoral drug delivery

Autor:innen und Institutionen

  • Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, CA, 92093, USA.
  • Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, CA, 92093, USA.

ORCID-Profile: Liangfang Zhang

Förderung

  • Defense Threat Reduction Agency

Zitieren

APA

Kubiatowicz, L. J., Pourafzal, N., Zhu, A. T., Guo, Z., Fang, R. H., & Zhang, L. (2026). Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers. Small Methods, 10(2). https://doi.org/10.1002/smtd.202500624

Vancouver

Kubiatowicz LJ, Pourafzal N, Zhu AT, Guo Z, Fang RH, Zhang L. Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers. Small Methods. 2026;10(2). doi:10.1002/smtd.202500624

BibTeX
@article{Kubiatowicz2026,
  author = {Kubiatowicz, Luke J and Pourafzal, Nima and Zhu, Audrey T and Guo, Zhongyuan and Fang, Ronnie H and Zhang, Liangfang},
  title = {Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers},
  journal = {Small Methods},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.1002/smtd.202500624}
}
Kostenlos starten →